{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:10:24Z","timestamp":1781953824909,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s43440-021-00341-0","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T14:02:25Z","timestamp":1638021745000},"page":"229-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial"],"prefix":"10.1007","volume":"74","author":[{"given":"Negar","family":"Toroghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladan","family":"Abbasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahid","family":"Nourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effat","family":"Davoudi-Monfared","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1590-6396","authenticated-orcid":false,"given":"Hossein","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malihe","family":"Hasannezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Ghiasvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirous","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Emadi-Kouchak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir Saeed","family":"Yekaninejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,27]]},"reference":[{"key":"341_CR1","unstructured":"World Health Organization, COVID-19 Weekly Epidemiological Update, 11 October 2021. 2021. https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---11-october-2021. Accessed 14 Oct 2021."},{"issue":"6","key":"341_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2023184","volume":"384","author":"WHO Solidarity Trial Consortium","year":"2021","unstructured":"WHO Solidarity Trial Consortium. Repurposed antiviral drugs for Covid-19\u2014Interim WHO solidarity trial results. N Engl J Med. 2021;384(6):497\u2013511. https:\/\/doi.org\/10.1056\/NEJMoa2023184.","journal-title":"N Engl J Med"},{"issue":"8","key":"341_CR3","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782\u201393. https:\/\/doi.org\/10.1001\/jama.2020.12839.","journal-title":"JAMA"},{"issue":"1","key":"341_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13054-020-02880-z","volume":"24","author":"L Gattinoni","year":"2020","unstructured":"Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care. 2020;24(1):154. https:\/\/doi.org\/10.1186\/s13054-020-02880-z.","journal-title":"Crit Care"},{"issue":"10228","key":"341_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30558-4","volume":"395","author":"T Wang","year":"2020","unstructured":"Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020;395(10228): e52. https:\/\/doi.org\/10.1016\/S0140-6736(20)30558-4.","journal-title":"Lancet"},{"issue":"1","key":"341_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa2030340","volume":"384","author":"C Salama","year":"2021","unstructured":"Salama C, Han J, Yau L, Reiss WG, Kramer B, Neidhart JD, et al. Tocilizumab in patients hospitalized with Covid-19 pneumonia. N Engl J Med. 2021;384(1):20\u201330. https:\/\/doi.org\/10.1056\/NEJMoa2030340.","journal-title":"N Engl J Med"},{"issue":"21","key":"341_CR7","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","volume":"383","author":"P Horby","year":"2020","unstructured":"RECOVERY Collaborative Group, Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, et al. Effect of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;383(21):2030\u201340. https:\/\/doi.org\/10.1056\/NEJMoa2022926.","journal-title":"N Engl J Med"},{"issue":"8","key":"341_CR8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436.","journal-title":"N Engl J Med"},{"issue":"27","key":"341_CR9","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1056\/NEJMp2032369","volume":"383","author":"D Rubin","year":"2020","unstructured":"Rubin D, Chan-Tack K, Farley J, Sherwat A. FDA approval of remdesivir\u2014a step in the right direction. N Engl J Med. 2020;383(27):2598\u2013600. https:\/\/doi.org\/10.1056\/NEJMp2032369.","journal-title":"N Engl J Med"},{"issue":"8","key":"341_CR10","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3390\/jcm9082392","volume":"9","author":"KH Lee","year":"2020","unstructured":"Lee KH, Yoon S, Jeong GH, Kim JY, Han YJ, Hong SH, et al. Efficacy of corticosteroids in patients with SARS, MERS and COVID-19: a systematic review and meta-analysis. J Clin Med. 2020;9(8):2392. https:\/\/doi.org\/10.3390\/jcm9082392.","journal-title":"J Clin Med"},{"issue":"11","key":"341_CR11","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00134-020-06223-y","volume":"46","author":"YM Arabi","year":"2020","unstructured":"Arabi YM, Chrousos GP, Meduri GU. The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Intensive Care Med. 2020;46(11):2067\u201370. https:\/\/doi.org\/10.1007\/s00134-020-06223-y.","journal-title":"Intensive Care Med"},{"issue":"1","key":"341_CR12","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1080\/22221751.2020.1807885","volume":"9","author":"Y Li","year":"2020","unstructured":"Li Y, Zhou X, Li T, Chan S, Yu Y, Ai JW, et al. Corticosteroid prevents COVID-19 progression within its therapeutic window: a multicentre, proof-of-concept, observational study. Emerg Microbes Infect. 2020;9(1):1869\u201377. https:\/\/doi.org\/10.1080\/22221751.2020.1807885.","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"341_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s40121-020-00337-y","volume":"9","author":"C Ding","year":"2020","unstructured":"Ding C, Feng X, Chen Y, Yuan J, Yi P, Li Y, et al. Effect of Corticosteroid therapy on the duration of SARS-CoV-2 clearance in patients with mild COVID-19: a retrospective cohort study. Infect Dis Ther. 2020;9(4):943\u201352. https:\/\/doi.org\/10.1007\/s40121-020-00337-y.","journal-title":"Infect Dis Ther"},{"issue":"6","key":"341_CR14","doi-asserted-by":"publisher","first-page":"2002808","DOI":"10.1183\/13993003.02808-2020","volume":"56","author":"M Edalatifard","year":"2020","unstructured":"Edalatifard M, Akhtari M, Salehi M, Naderi Z, Jamshidi A, Mostafaei S, et al. Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J. 2020;56(6):2002808. https:\/\/doi.org\/10.1183\/13993003.02808-2020.","journal-title":"Eur Respir J"},{"key":"341_CR15","doi-asserted-by":"crossref","unstructured":"World Health Organization. 2020. Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/332196.","DOI":"10.15557\/PiMR.2020.0004"},{"issue":"4","key":"341_CR16","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179\u201384. https:\/\/doi.org\/10.1159\/000339789.","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"341_CR17","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1097\/ALN.0b013e318266c6df","volume":"117","author":"T Lescot","year":"2012","unstructured":"Lescot T, Karvellas C, Beaussier M, Magder S. Acquired liver injury in the intensive care unit. Anesthesiology. 2012;117(4):898\u2013904. https:\/\/doi.org\/10.1097\/ALN.0b013e318266c6df.","journal-title":"Anesthesiology"},{"issue":"2","key":"341_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, ESC Scientific Document Group, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393.","journal-title":"Eur Heart J"},{"issue":"47","key":"341_CR19","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.1093\/eurheartj\/ehx003","volume":"39","author":"L Mazzolai","year":"2018","unstructured":"Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur Heart J. 2018;39(47):4208\u201318. https:\/\/doi.org\/10.1093\/eurheartj\/ehx003.","journal-title":"Eur Heart J"},{"key":"341_CR20","unstructured":"Neter J, Kutner MH, Nachtsheim CJ, et al. Applied linear statistical models. 5th Edition, McGraw-Hill, Irwin, New York; 2005."},{"issue":"12","key":"341_CR21","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1164\/rccm.200306-766OC","volume":"168","author":"JC Ho","year":"2003","unstructured":"Ho JC, Ooi GC, Mok TY, Chan JW, Hung I, Lam B, et al. High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med. 2003;168(12):1449\u201356. https:\/\/doi.org\/10.1164\/rccm.200306-766OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"341_CR22","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1378\/chest.129.6.1441","volume":"129","author":"RC Chen","year":"2006","unstructured":"Chen RC, Tang XP, Tan SY, Liang BL, Wan ZY, Fang JQ, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest. 2006;129(6):1441\u201352. https:\/\/doi.org\/10.1378\/chest.129.6.1441.","journal-title":"Chest"},{"issue":"6","key":"341_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","volume":"197","author":"YM Arabi","year":"2018","unstructured":"Arabi YM, Mandourah Y, Al-Hameed F, Sindi AA, Almekhlafi GA, Hussein MA, Saudi Critical Care Trial Group, et al. Corticosteroid therapy for critically ill patients with Middle East Respiratory syndrome. Am J Respir Crit Care Med. 2018;197(6):757\u201367. https:\/\/doi.org\/10.1164\/rccm.201706-1172OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"341_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jinf.2020.03.039","volume":"81","author":"X Fang","year":"2020","unstructured":"Fang X, Mei Q, Yang T, Li L, Wang Y, Tong F, et al. Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19. J Infect. 2020;81(1):147\u201378. https:\/\/doi.org\/10.1016\/j.jinf.2020.03.039.","journal-title":"J Infect"},{"issue":"1","key":"341_CR25","doi-asserted-by":"publisher","first-page":"21291","DOI":"10.1038\/s41598-020-78039-1","volume":"10","author":"V Spagnuolo","year":"2020","unstructured":"Spagnuolo V, Guffanti M, Galli L, Poli A, Querini PR, Ripa M, COVID-BioB study group, et al. Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19. Sci Rep. 2020;10(1):21291. https:\/\/doi.org\/10.1038\/s41598-020-78039-1 (Erratum in: Sci Rep. 2021 May 17;11(1):10699).","journal-title":"Sci Rep"},{"key":"341_CR26","doi-asserted-by":"publisher","first-page":"173556","DOI":"10.1016\/j.ejphar.2020.173556","volume":"889","author":"R Huang","year":"2020","unstructured":"Huang R, Zhu C, Jian W, Xue L, Li C, Yan X, et al. Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients. Eur J Pharmacol. 2020;889:173556. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173556.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"341_CR27","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/cid\/ciaa829","volume":"72","author":"S Li","year":"2021","unstructured":"Li S, Hu Z, Song X. High-dose but not low-dose corticosteroids potentially delay viral shedding of patients with COVID-19. Clin Infect Dis. 2021;72(7):1297\u20138. https:\/\/doi.org\/10.1093\/cid\/ciaa829.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"341_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar J, Ferrando C, Mart\u00ednez D, Ambr\u00f3s A, Mu\u00f1oz T, Soler JA, et al. Dexamethasone in ARDS network. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267\u201376. https:\/\/doi.org\/10.1016\/S2213-2600(19)30417-5.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"341_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cmi.2020.09.014","volume":"27","author":"M Bartoletti","year":"2021","unstructured":"Bartoletti M, Marconi L, Scudeller L, Pancaldi L, Tedeschi S, Giannella M, PREDICO Study Group, et al. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicenter study. Clin Microbiol Infect. 2021;27(1):105\u201311. https:\/\/doi.org\/10.1016\/j.cmi.2020.09.014.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"341_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243964.PMID:33507958;PMCID:PMC7842890","volume":"16","author":"M\u00c1 L\u00f3pez Z\u00fa\u00f1iga","year":"2021","unstructured":"L\u00f3pez Z\u00fa\u00f1iga M\u00c1, Moreno-Moral A, Oca\u00f1a-Granados A, Padilla-Moreno FA, Castillo-Fern\u00e1ndez AM, Guillam\u00f3n-Fern\u00e1ndez D, et al. High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response. PLoS ONE. 2021;16(1): e0243964. https:\/\/doi.org\/10.1371\/journal.pone.0243964.PMID:33507958;PMCID:PMC7842890.","journal-title":"PLoS ONE"},{"issue":"7","key":"341_CR31","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s11739-021-02800-1","volume":"16","author":"A Vecchi\u00e9","year":"2021","unstructured":"Vecchi\u00e9 A, Batticciotto A, Tangianu F, Bonaventura A, Pennella B, Abenante A, et al. High-dose dexamethasone treatment for COVID-19 severe acute respiratory distress syndrome: a retrospective study. Intern Emerg Med. 2021;16(7):1913\u20139. https:\/\/doi.org\/10.1007\/s11739-021-02800-1.","journal-title":"Intern Emerg Med"},{"issue":"2","key":"341_CR32","doi-asserted-by":"publisher","first-page":"e13458","DOI":"10.1111\/eci.13458","volume":"51","author":"A Papamanoli","year":"2021","unstructured":"Papamanoli A, Yoo J, Grewal P, Predun W, Hotelling J, Jacob R, et al. High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia. Eur J Clin Invest. 2021;51(2):e13458. https:\/\/doi.org\/10.1111\/eci.13458 (Epub 2020 Dec 1).","journal-title":"Eur J Clin Invest"},{"issue":"16","key":"341_CR33","doi-asserted-by":"publisher","first-page":"117727192110216","DOI":"10.1177\/11772719211021647","volume":"4","author":"K Tromp","year":"2021","unstructured":"Tromp K, van der Zee P, Rokx C, van Kampen J, Gommers D, Endeman H. Effect of methylprednisolone on inflammation and coagulation in patients with severe COVID-19: a retrospective cohort study. Biomark Insights. 2021;4(16):11772719211021648. https:\/\/doi.org\/10.1177\/11772719211021647.","journal-title":"Biomark Insights"},{"issue":"9","key":"341_CR34","doi-asserted-by":"publisher","first-page":"14479","DOI":"10.1111\/ijcp.14479","volume":"75","author":"M Climente-Mart\u00ed","year":"2021","unstructured":"Climente-Mart\u00ed M, Ruiz-Millo O, L\u00f3pez-Cruz I, Atienza-Garc\u00eda \u00c1, Mart\u00ednez-Morag\u00f3n E, Garijo-G\u00f3mez E, Doctor Peset COVID-19 Working Group, et al. Impact of intermediate to high doses of methylprednisolone on mortality rate in patients with COVID-19 pneumonia-indu. Int J Clin Pract. 2021;75(9):14479. https:\/\/doi.org\/10.1111\/ijcp.14479.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"341_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252057","volume":"16","author":"MA Pinz\u00f3n","year":"2021","unstructured":"Pinz\u00f3n MA, Ortiz S, Holgu\u00edn H, Betancur JF, Cardona Arango D, Laniado H, et al. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia. PLoS ONE. 2021;16(5): e0252057. https:\/\/doi.org\/10.1371\/journal.pone.0252057.","journal-title":"PLoS ONE"},{"key":"341_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2021.100716","volume":"21","author":"X Solanich","year":"2021","unstructured":"Solanich X, Antol\u00ed A, Padull\u00e9s N, Fanlo-Maresma M, Iriarte A, Mitjavila F, et al. Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: the TACROVID trial protocol. Contemp Clin Trials Commun. 2021;21: 100716. https:\/\/doi.org\/10.1016\/j.conctc.2021.100716.","journal-title":"Contemp Clin Trials Commun"},{"issue":"13","key":"341_CR37","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.2020.17021","volume":"324","author":"BM Tomazini","year":"2020","unstructured":"Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, COALITION COVID-19 Brazil III Investigators, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020;324(13):1307\u201316. https:\/\/doi.org\/10.1001\/jama.2020.17021.","journal-title":"JAMA"},{"issue":"16","key":"341_CR38","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/cid\/ciaa601","volume":"71","author":"R Fadel","year":"2020","unstructured":"Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, Henry Ford COVID-19 Management Task Force, et al. Early short-course corticosteroids in hospitalized patients with COVID-19. Clin Infect Dis. 2020;71(16):2114\u201320. https:\/\/doi.org\/10.1093\/cid\/ciaa601.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"341_CR39","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/0885066621994057","volume":"36","author":"JJ Ko","year":"2021","unstructured":"Ko JJ, Wu C, Mehta N, Wald-Dickler N, Yang W, Qiao R. A Comparison of methylprednisolone and dexamethasone in intensive care patients with COVID-19. J Intensive Care Med. 2021;36(6):673\u201380. https:\/\/doi.org\/10.1177\/0885066621994057.","journal-title":"J Intensive Care Med"},{"issue":"1","key":"341_CR40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12879-021-06045-3","volume":"21","author":"K Ranjbar","year":"2021","unstructured":"Ranjbar K, Moghadami M, Mirahmadizadeh A, Fallahi MJ, Khaloo V, Shahriarirad R, et al. Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial. BMC Infect Dis. 2021;21(1):337. https:\/\/doi.org\/10.1186\/s12879-021-06045-3.","journal-title":"BMC Infect Dis"},{"issue":"13","key":"341_CR41","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2020.17022","volume":"324","author":"DC Angus","year":"2020","unstructured":"Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A, et al. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA. 2020;324(13):1317\u201329. https:\/\/doi.org\/10.1001\/jama.2020.17022.","journal-title":"JAMA"},{"issue":"1","key":"341_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","volume":"27","author":"C Garcia-Vidal","year":"2021","unstructured":"Garcia-Vidal C, Sanjuan G, Moreno-Garc\u00eda E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, COVID-19 Researchers Group, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.041.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"341_CR43","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4239\/wjd.v6.i8.1073","volume":"6","author":"HE Tamez-P\u00e9rez","year":"2015","unstructured":"Tamez-P\u00e9rez HE, Quintanilla-Flores DL, Rodr\u00edguez-Guti\u00e9rrez R, Gonz\u00e1lez-Gonz\u00e1lez JG, Tamez-Pe\u00f1a AL. Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review. World J Diabetes. 2015;6(8):1073\u201381. https:\/\/doi.org\/10.4239\/wjd.v6.i8.1073.","journal-title":"World J Diabetes"},{"key":"341_CR44","unstructured":"Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. 2021. https:\/\/www.covid19treatmentguidelines.nih.gov\/. Accessed 14 Oct 2021."},{"key":"341_CR45","unstructured":"- Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC et al. Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19. Infectious Diseases Society of America\u00a02021; Version 5.3.1. 2021. https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-treatment-and-management\/. Accessed 14 Oct 2021."},{"key":"341_CR46","doi-asserted-by":"publisher","first-page":"ciab875","DOI":"10.1093\/cid\/ciab875","volume":"2021","author":"E Mozaffari","year":"2021","unstructured":"Mozaffari E, Chandak A, Zhang Z, Liang S, Thrun M, Gottlieb RL, et al. Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort. Clin Infect Dis. 2021;2021:ciab875. https:\/\/doi.org\/10.1093\/cid\/ciab875.","journal-title":"Clin Infect Dis"},{"key":"341_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00485-0","author":"F Ader","year":"2021","unstructured":"Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, DisCoVeRy Study Group, et al. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Lancet Infect Dis. 2021. https:\/\/doi.org\/10.1016\/S1473-3099(21)00485-0.","journal-title":"Lancet Infect Dis"},{"issue":"346","key":"341_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e8668","volume":"21","author":"ML Bell","year":"2013","unstructured":"Bell ML, Kenward MG, Fairclough DL, Horton NJ. Differential dropout and bias in randomised controlled trials: when it matters and when it may not. BMJ. 2013;21(346): e8668. https:\/\/doi.org\/10.1136\/bmj.e8668.","journal-title":"BMJ"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00341-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-021-00341-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00341-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T02:37:17Z","timestamp":1643078237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-021-00341-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["341"],"URL":"https:\/\/doi.org\/10.1007\/s43440-021-00341-0","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,27]]},"assertion":[{"value":"19 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest for authors to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee of Tehran University of Medical Sciences approved the study (reference number: IR.TUMS.MEDICINE.REC.1399.430).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Inform consent was obtained from all participants or from a responsible first-degree family member.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}